MedPath

A RANDOMIZED CONTROL TRIAL TO FIND OUT THE INCIDENCE OF SURGICAL SITE INFECTIONS IN PATIENTS RECEIVING REDUCED DOSES OF STEROID AS PRE-MEDICATION IN PATIENTS RECEIVING NEO-ADJUVANT CHEMOTHERAPY FOR BREAST CANCER

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2024/07/071498
Lead Sponsor
Post Graduate Institute of Medical Education and Research,Chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All patients with biopsy proven breast carcinoma

2.All female patients falling under age group of 18-70

3.Patients willing to provide valid written consent

Exclusion Criteria

1.Those who already received chemotherapy.

2.Recurrence patients and those who received palliative chemotherapy.

3.Patients with cardiac comorbidities.

4.Pregnant patients.

5.Patients on steroids for other systemic diseases.

6.ASA grade III & IV.

7.Cushing’s syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath